NYSE$OSCR
Oscar Health Inc · Q4 2022 earnings
Q4 2022 earnings · · Investor relations
Briefing
Oscar Health's financial performance showed improvement in core operating margins and key metrics.
Oscar Health's Q4 2022 results demonstrated significant year-over-year improvement in core operating margins. The company's focus on cost management and administrative efficiency has positioned it well for future profitability.
- Membership increased by 93% year-over-year, reaching 1,151,483 members as of December 31, 2022.
- The InsuranceCo Combined Ratio improved by approximately 5 points year-over-year.
- Oscar Health is introducing its outlook for 2023 with an anticipated InsuranceCo Combined Ratio at or less than 100%.
- The company anticipates Direct and Assumed Policy Premiums of $6.4 billion to $6.6 billion for 2023.
Headline financials
Revenue & EPS history
Oscar Health · Revenue · Quarterly
$995M
Forward guidance
The Company is introducing its outlook for 2023 including anticipated Direct and Assumed Policy Premiums of $6.4 billion to $6.6 billion, an InsuranceCo Combined Ratio at or less than 100%, and a significantly improved Adjusted EBITDA loss of ($175) million to ($75) million.
Tailwinds
- Direct and Assumed Policy Premiums of $6,400,000 to $6,600,000
- Medical Loss Ratio of 82% to 84%
- InsuranceCo Administrative Expense Ratio of 17% to 18%
- InsuranceCo Adjusted EBITDA of $20,000 to $120,000
- Adjusted Administrative Expense Ratio of 20.5% to 21.5%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2022
+3.7%
Avg return
Earnings day
+5.6%
Avg return
5 days after
+7.5%
Avg return
30 days after
64%
16 / 25 earnings
Positive
+30.0%
Q1 2025
Best reaction
-23.9%
Q3 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.7% | +22.6% | +36.6% | |
| Q4 2025 | +1.7% | +6.0% | +2.7% | |
| Q3 2025 | -2.8% | -12.8% | -1.5% | |
| Q1 2025 | +30.0% | +28.7% | +18.0% | |
| Q4 2024 | +3.1% | -3.7% | +4.5% | |
| Q3 2024 | -12.9% | -12.8% | +0.4% | |
| Q2 2024 | +7.2% | +4.4% | -1.4% | |
| Q1 2024 | +9.3% | +14.1% | +2.8% | |
| Q4 2023 | +22.7% | +27.5% | +7.7% | |
| Q3 2023 | +23.5% | +24.5% | +42.0% | |
| Q2 2023 | +8.6% | +1.9% | -10.5% | |
| Q1 2023 | -8.8% | -6.6% | +17.8% | |
| Q4 2022 | +21.0% | +36.2% | -3.9% | |
| Q3 2022 | -23.9% | -4.5% | -11.3% | |
| Q2 2022 | +19.9% | +21.1% | -3.7% | |
| Q1 2022 | -8.9% | -2.0% | -25.0% | |
| Q4 2019 | +6.3% | +2.5% | +39.1% | |
| Q4 2021 | +2.4% | +15.6% | +21.9% | |
| Q3 2020 | -2.4% | -6.3% | -12.7% | |
| Q3 2021 | -23.3% | -25.2% | -33.0% | |
| Q2 2020 | -16.4% | -11.8% | +19.4% | |
| Q2 2021 | -0.9% | -12.0% | +17.9% | |
| Q4 2020 | +15.2% | +14.5% | +23.1% | |
| Q1 2020 | +15.2% | +14.5% | +23.1% | |
| Q1 2021 | +3.6% | +4.2% | +14.0% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro